9 research outputs found
ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΡΠΈΠ½ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ
Acute respiratory viral infections remain the most common diseases in the world, accounting for about 90% of all infectious diseases. The possibilities of etiological decoding of ARVI using modern examination methods made it possible to establish an increase in the proportion of rhinovirus infection in the structure of ARVI.The aim of the study in this regard was to study the features of the clinical course of rhinovirus infection in children of different ages in modern conditions. The study included 50 patients with rhinovirus infection of children, among whom 1 2 children (24%) were under 1 year old; 34 children (68%) β 1β3 years old, 4 children (8%) β 3β7 years old. To confirm rhinovirus infection, a study of mucus from the nasopharynx by PCR was carried out.A thorough analysis of the symptom complex of the infection showed that in 1 3 (26%) patients the infectious process was limited to lesions of the upper respiratory tract, in 14 (28%) there were symptoms of acute stenosinglaryngotracheitis, in 1 1 (22%) children developed pneumonia, in 1 2 (24%) β bronchitis, with obstructive syndrome in 1 0 (83.3%) patients in this group.ΠΡΡΡΡΠ΅ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠ΅ Π²ΠΈΡΡΡΠ½ΡΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΎΡΡΠ°ΡΡΡΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π² ΠΌΠΈΡΠ΅, ΡΠΎΡΡΠ°Π²Π»ΡΡ ΠΎΠΊΠΎΠ»ΠΎ 90% Π²ΡΠ΅ΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ. ΠΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ°ΡΡΠΈΡΡΠΎΠ²ΠΊΠΈ ΠΠ ΠΠ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»ΠΈ ΡΡΡΠ°Π½ΠΎΠ²ΠΈΡΡ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ Π΄ΠΎΠ»ΠΈ ΡΠΈΠ½ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Π² ΡΡΡΡΠΊΡΡΡΠ΅ ΠΠ ΠΠ.Π¦Π΅Π»ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ²ΠΈΠ»ΠΎΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΡΠΈΠ½ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠ³ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ° Π² ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΡΡΠ»ΠΎΠ²ΠΈΡΡ
.ΠΠΎΠ΄ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ΠΌ Π½Π°Ρ
ΠΎΠ΄ΠΈΠ»ΠΎΡΡ 50 Π΄Π΅ΡΠ΅ΠΉ Ρ ΡΠΈΠ½ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ: 12 Π΄Π΅ΡΠ΅ΠΉ (24%) Π±ΡΠ»ΠΈ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ Π΄ΠΎ 1 Π³ΠΎΠ΄Π°; 34 ΡΠ΅Π±Π΅Π½ΠΊΠ° (68%) β 1 β3 Π»Π΅Ρ, 4 ΡΠ΅Π±Π΅Π½ΠΊΠ° (8%) β 3β7 Π»Π΅Ρ. ΠΠ»Ρ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ΠΈΡ ΡΠΈΠ½ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ»ΠΈΠ·ΠΈ ΠΈΠ· Π½ΠΎΡΠΎΠ³Π»ΠΎΡΠΊΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ¦Π .Π’ΡΠ°ΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ° ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΏΠΎΠΊΠ°Π·Π°Π», ΡΡΠΎ ΡΠΎΠ»ΡΠΊΠΎ Ρ 13 (26%) Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΠΉ ΠΏΡΠΎΡΠ΅ΡΡ ΠΎΠ³ΡΠ°Π½ΠΈΡΠΈΠ²Π°Π»ΡΡ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡΠΌΠΈ Π²Π΅ΡΡ
Π½ΠΈΡ
Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΠΏΡΡΠ΅ΠΉ, Ρ 14 (28%) ΠΎΡΠΌΠ΅ΡΠ°Π»ΠΈΡΡ ΡΠ²Π»Π΅Π½ΠΈΡ ΠΎΡΡΡΠΎΠ³ΠΎ ΡΡΠ΅Π½ΠΎΠ·ΠΈΡΡΡΡΠ΅Π³ΠΎ Π»Π°ΡΠΈΠ½Π³ΠΎΡΡΠ°Ρ
Π΅ΠΈΡΠ°, Ρ 1 1 (22%) Π΄Π΅ΡΠ΅ΠΉ ΡΠ°Π·Π²ΠΈΠ²Π°Π»ΠΈΡΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ, Ρ 12 (24%) β Π±ΡΠΎΠ½Ρ
ΠΈΡΡ, ΠΏΡΠΈΡΡΠΌ Ρ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ Ρ 1 0 (83,3%) ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΡΡΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅
Peculiarities of the influenza viruses circulation and their properties during 2018-2019 epidemic season in Russia and countries of the Northern Hemisphere
Objective. To identify the drift variability of influenza viruses during the period of epidemic rise in the incidence of acute respiratory viral infections in the period 2018-2019. The biological and molecular-genetic properties of epidemic strains isolated in certain territories of the Russian Federation were studied and compared with data from the countries of the Northern Hemisphere. Materials and methods. A range of laboratory diagnostic methods has been applied, including immune fluorescence, RT-PCR, sequencing, methods for determining sensitivity to influenza drugs and receptor specificity. Results and discussion. The proportion of influenza viruses was as follows: A (H1N1) pdm09 - 53 %, A (H3N2) - 46 %, B - about 1 %. Cases of severe acute respiratory infections have most often been associated with influenza A(H1N1) pdm09 virus. According to antigenic properties, isolated strains corresponded to the properties of vaccine viruses (A/Michigan/45/2015 - by 99.6 % and A/Singapore INFIMH-16-0019/2016 - by 86 %). The heterogeneity of influenza A virus strains population was revealed as regards individual mutations in hemaglutinin. The influenza B virus population was equally represented by both evolutionary lines (B/Victoria and B/Yamagata-like). Receptor specificity was favorable for the course and outcome of the disease. Among 70 studied epidemic strains, no strains resistant to anti-neuraminidase drugs, oseltamivir and zanamivir, were detected. The article presents WHO recommendations on the composition of influenza vaccines for the countries of the Northern Hemisphere for 2019-2020, provides data on cases of human infection with avian influenza viruses A(H5N1), A(H5N6), A(H7N9) and A(H9N2)
ΠΠ°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ Π³ΡΠΈΠΏΠΏΠΎΠΌ Π² ΡΠ½Π²Π°ΡΠ΅-ΠΌΠ°ΡΡΠ΅ 2016 Π³. Π² Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ: ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΈ ΠΏΠ°Π½Π΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π» Π²ΠΈΡΡΡΠ° Π³ΡΠΈΠΏΠΏΠ° A(H1N1)pdm09
The World Health Organization (WHO) searches influenza virus circulation in community and in natural biocenosis, studies virus strains and their properties, develops diagnostic methods and preventive measures since 1940th worldwide because of epidemic actuality and high pandemic potential of the influenza virus. The Federal Influenza Center (including Federal Research Institute of Influenza, Saint-Petersburg, and the Center of Virus Ecology, D.I.Ivanovskiy Virology Institute, Honorary Academician N.F.GamaleyaFederal Research Center of Epidemiology and Microbiology, Federal Research Center for Epidemiology and Microbiology, Moscow) performs similar work in Russia in close cooperation with WHO within the framework of the International Programme of Influenza Monitoring. A(H1N1)pdm09 influenza virus dominated in the Northern Hemisphere in the 2015 β 2016 epidemic season. Morbidity growth was noted from the end of January, 2016, to the beginning of March, 2016. The peak morbidity at the 5th week of the year exceeded the epidemic threshold (132 cases per 10,000 of population) and morbidity in the 2014 β 2015 season significantly and approached to the peak morbidity of the 2009 β 2010 epidemic season. The epidemic growth in Russian Federation was provided by three influenza viruses: A(H1N1)pdm09, Π and A (H3N2). A(H1N1)pdm09 virus caused 18% of all acute respiratory diseases and accounted for 84% of circulating influenza viruses.Flu was diagnosed in patients of different age with maximal frequency in 3- to 6-year old children. Peak admission number was registered at 5 and 6 weeks (3,538 and 4,109 cases, respectively); this number exceeded the similar parameter of the 2009 β 2010 season. Patients of 15 to 64 years old were admitted more often including those with acute respiratory infection. Two hundred and thirty nine deaths were registered to the 5th of April, 2016, according to data from the Federal Influenza Center and the Center of Virus Ecology. The diagnosis of A(H1N1)pdm09 flu was confirmed in 97.9% of deaths. Molecular analysis of isolated strains of A(H1N1)pdm09 influenza virus revealed amino acid substitutions in receptor binding site and SA site of hemagglutinin and in genes coding intrinsic proteins PA, NP, M1, and NS1. Influenza virus strains resistive to anti-neuraminidase drugs were encountered in #< 1% in the Northern Hemisphere countries. No strains studied were sensitive to adamantine derivates.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. Π‘ 1947 Π³. Π² ΡΠ²ΡΠ·ΠΈ Ρ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡΡ ΠΈ Π²ΡΡΠΎΠΊΠΈΠΌ ΠΏΠ°Π½Π΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΠΎΠΌ Π²ΠΈΡΡΡΠ° Π³ΡΠΈΠΏΠΏΠ° ΡΠΈΠΏΠ° Π ΠΏΠΎ ΠΈΠ½ΠΈΡΠΈΠ°ΡΠΈΠ²Π΅ ΠΡΠ΅ΠΌΠΈΡΠ½ΠΎΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ (ΠΠΠ) ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΎΠ²Π°Π½Π° ΠΠ»ΠΎΠ±Π°Π»ΡΠ½Π°Ρ ΡΠΈΡΡΠ΅ΠΌΠ° ΠΏΠΎ Π½Π°Π΄Π·ΠΎΡΡ Π·Π° Π³ΡΠΈΠΏΠΏΠΎΠΌ ΠΈ ΠΎΡΠ²Π΅ΡΡ (Global Influenza Surveillance and Response System β GISRS), ΠΊΠΎΡΠΎΡΠ°Ρ Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π° 6 ΡΠΎΡΡΡΠ΄Π½ΠΈΡΠ°ΡΡΠΈΠΌΠΈ ΡΠ΅Π½ΡΡΠ°ΠΌΠΈ ΠΏΠΎ Π³ΡΠΈΠΏΠΏΡ, 143 Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΌΠΈ ΡΠ΅Π½ΡΡΠ°ΠΌΠΈ ΠΏΠΎ Π³ΡΠΈΠΏΠΏΡ Π² 113 ΡΡΡΠ°Π½Π°Ρ
, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡΠ΅Π»ΡΠΌΠΈ Π³ΡΠΈΠΏΠΏΠΎΠ·Π½ΡΡ
Π²Π°ΠΊΡΠΈΠ½. Π ΠΎΡΡΠΈΠΉΡΠΊΠ°Ρ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΡ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π° Π² ΡΡΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΠ΅ Π΄Π²ΡΠΌΡ Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΌΠΈ ΡΠ΅Π½ΡΡΠ°ΠΌΠΈ β Π€Π΅Π΄Π΅ΡΠ°Π»ΡΠ½ΡΠΌ ΡΠ΅Π½ΡΡΠΎΠΌ ΠΏΠΎ Π³ΡΠΈΠΏΠΏΡ (Π€Π¦Π) Π€ΠΠΠ£ Β«ΠΠ°ΡΡΠ½ΠΎ-ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΡΠΊΠΈΠΉ ΠΈΠ½ΡΡΠΈΡΡΡ Π³ΡΠΈΠΏΠΏΠ°Β» ΠΠΈΠ½Π·Π΄ΡΠ°Π²Π° Π ΠΎΡΡΠΈΠΈ (Π‘Π°Π½ΠΊΡ-ΠΠ΅ΡΠ΅ΡΠ±ΡΡΠ³) ΠΈ Π¦Π΅Π½ΡΡΠΎΠΌ ΡΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ Π³ΡΠΈΠΏΠΏΠ° (Π¦ΠΠΠ) ΠΠ½ΡΡΠΈΡΡΡΠ° Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈΠΌ. Π.Π.ΠΠ²Π°Π½ΠΎΠ²ΡΠΊΠΎΠ³ΠΎ Π€ΠΠΠ£ Β«Π€Π΅Π΄Π΅ΡΠ°Π»ΡΠ½ΡΠΉ Π½Π°ΡΡΠ½ΠΎ-ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΡΠΊΠΈΠΉ ΡΠ΅Π½ΡΡ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ ΠΌΠΈΠΊΡΠΎΠ±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈΠΌΠ΅Π½ΠΈ ΠΏΠΎΡΠ΅ΡΠ½ΠΎΠ³ΠΎ Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠ° Π.Π€.ΠΠ°ΠΌΠ°Π»Π΅ΠΈΒ» ΠΠΈΠ½Π·Π΄ΡΠ°Π²Π° Π ΠΎΡΡΠΈΠΈ (ΠΠΎΡΠΊΠ²Π°). ΠΠ±Π° ΡΠ΅Π½ΡΡΠ° ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΡΡ Π΅ΠΆΠ΅Π½Π΅Π΄Π΅Π»ΡΠ½ΡΠΉ Π½Π°Π΄Π·ΠΎΡ Π·Π° ΡΠΈΡΠΊΡΠ»ΡΡΠΈΠ΅ΠΉ Π²ΠΈΡΡΡΠΎΠ² Π³ΡΠΈΠΏΠΏΠ° Π² 59 Π³ΠΎΡΠΎΠ΄Π°Ρ
Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ, ΠΊΠΎΡΠΎΡΡΠΉ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅Ρ Π°Π½Π°Π»ΠΈΠ· Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ, Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ, Π»Π΅ΡΠ°Π»ΡΠ½ΡΡ
ΡΠ»ΡΡΠ°Π΅Π² ΠΎΡ Π³ΡΠΈΠΏΠΏΠ° ΠΈ ΠΎΡΡΡΠΎΠΉ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ (ΠΠ ΠΠ) Π² ΡΠ°Π·Π½ΡΡ
Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΡΡ
Π³ΡΡΠΏΠΏΠ°Ρ
, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠΈΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΏΠ΅ΠΊΡΡΠ° Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ². ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΡΡΡΠ°Π½Π°Ρ
Π‘Π΅Π²Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ»ΡΡΠ°ΡΠΈΡ Π² ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΠ΅Π·ΠΎΠ½Π΅ 2015β2016 Π³Π³. Π² ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΏΠΎΠ΄ΡΠ΅ΠΌΠ° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ Π΄ΠΎΠΌΠΈΠ½ΠΈΡΠΎΠ²Π°Π» Π²ΠΈΡΡΡ Π³ΡΠΈΠΏΠΏΠ° A(H1N1)pdm09. ΠΠΎΠ΄ΡΠ΅ΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ Π³ΡΠΈΠΏΠΏΠΎΠΌ Π² Π ΠΎΡΡΠΈΠΈ Π·Π°ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π½ Ρ ΠΊΠΎΠ½ΡΠ° ΡΠ½Π²Π°ΡΡ Π΄ΠΎ Π½Π°ΡΠ°Π»Π° ΠΌΠ°ΡΡΠ° 2016 Π³. ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ Π½Π° ΠΏΠΈΠΊΠ΅ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΈ (5-Ρ Π½Π΅Π΄Π΅Π»Ρ 2016 Π³.), Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΠΏΡΠ΅Π²ΡΡΠΈΠ² ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΠΎΡΠΎΠ³ (132 ΡΠ»ΡΡΠ°Ρ Π½Π° 10 ΡΡΡ. Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ) ΠΈ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΡΠ΅Π·ΠΎΠ½Π° 2014β2015 Π³Π³., ΠΎΡΠΌΠ΅ΡΠ΅Π½ Π½Π° ΡΡΠΎΠ²Π½Π΅ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅Π·ΠΎΠ½Π° 2009β2010 Π³Π³. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΡΡ ΡΡΡΡΠΊΡΡΡΡ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠΎΠ΄ΡΠ΅ΠΌΠ° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ Π² Π Π€ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΠ»ΠΈ 3 Π²ΠΈΡΡΡΠ° Π³ΡΠΈΠΏΠΏΠ° β A(H1N1)pdm09, Π ΠΈ A(H3N2) ΠΏΡΠΈ ΡΠ°Π·Π½ΠΎΠΌ Π΄ΠΎΠ»Π΅Π²ΠΎΠΌ ΡΡΠ°ΡΡΠΈΠΈ. ΠΡΠΈΠΏΠΏ A(H1N1)pdm09 Π² ΡΡΡΡΠΊΡΡΡΠ΅ ΠΠ ΠΠ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 18,0 %, Π² ΡΡΡΡΠΊΡΡΡΠ΅ ΡΠΈΡΠΊΡΠ»ΠΈΡΡΡΡΠΈΡ
Π²ΠΈΡΡΡΠΎΠ² Π³ΡΠΈΠΏΠΏΠ° β 84,0 %. ΠΠ°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ Π·Π°ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π½Π° Π²ΠΎ Π²ΡΠ΅Ρ
Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΡΡ
Π³ΡΡΠΏΠΏΠ°Ρ
. Πα½ΉΠ»ΡΡΠ°Ρ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½Π½ΠΎΡΡΡ Π² ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΡΠΎΡΠ΅ΡΡ Π·Π°ΡΠΈΠΊΡΠΈΡΠΎΠ²Π°Π½Π° Ρ Π΄Π΅ΡΠ΅ΠΉ 3β6 Π»Π΅Ρ. ΠΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠ΅ ΡΠΈΡΠ»ΠΎ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΉ ΠΎΡΠΌΠ΅ΡΠ΅Π½ΠΎ Π½Π° 5-ΠΉ ΠΈ 6-ΠΉ Π½Π΅Π΄Π΅Π»ΡΡ
2016 Π³. β 3Β 538 ΠΈ 4Β 109 ΡΠ»ΡΡΠ°Π΅Π² ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ, ΡΡΠΎ ΠΏΡΠ΅Π²ΡΡΠΈΠ»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΠ΅Π·ΠΎΠ½Π° 2009β2010 Π³Π³. ΠΠ°ΠΈΠ±ΠΎΠ»ΡΡΠ΅Π΅ ΡΠΈΡΠ»ΠΎ ΡΠ»ΡΡΠ°Π΅Π² Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ, Π² Ρ. Ρ. Ρ ΡΡΠΆΠ΅Π»ΠΎΠΉ ΠΎΡΡΡΠΎΠΉ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ, ΠΎΡΠΌΠ΅ΡΠ΅Π½ΠΎ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅ 15β64 Π»Π΅Ρ. ΠΠΎ Π΄Π°Π½Π½ΡΠΌ Π€Π¦Π ΠΈ Π¦ΠΠΠ, Π½Π° 05.04.16 Π·Π°ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π½ΠΎ 239 Π»Π΅ΡΠ°Π»ΡΠ½ΡΡ
ΠΈΡΡ
ΠΎΠ΄ΠΎΠ². Π 97,9 % ΡΠ»ΡΡΠ°Π΅Π² Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΠΌΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΠΌΠΈ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ Π³ΡΠΈΠΏΠΏ A(H1N1)pdm09. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Π²ΡΠ΄Π΅Π»Π΅Π½Π½ΡΡ
ΡΡΠ°ΠΌΠΌΠΎΠ² Π²ΠΈΡΡΡΠ° Π³ΡΠΈΠΏΠΏΠ° A / H1N1pdm09 ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ Π½Π°Π»ΠΈΡΠΈΠ΅ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΡ
Π·Π°ΠΌΠ΅Π½ Π² Π³Π΅ΠΌΠ°Π³Π³Π»ΡΡΠΈΠ½ΠΈΠ½Π΅ (ΡΠ΅ΡΠ΅ΠΏΡΠΎΡ-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠ΅ΠΌ ΠΈ Sa ΡΠ°ΠΉΡΠ°Ρ
) ΠΈ Π² Π³Π΅Π½Π°Ρ
, ΠΊΠΎΠ΄ΠΈΡΡΡΡΠΈΡ
Π²Π½ΡΡΡΠ΅Π½Π½ΠΈΠ΅ Π±Π΅Π»ΠΊΠΈ (PA, NP, M1, NS1). ΠΠΎΠ»Ρ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΡΡΠ°ΠΌΠΌΠΎΠ² ΠΊ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ Ρ Π°Π½ΡΠΈΠ½Π΅ΠΉΡΠ°ΠΌΠΈΠ½ΠΈΠ΄Π°Π·Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ Π² ΡΡΡΠ°Π½Π°Ρ
Π‘Π΅Π²Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ»ΡΡΠ°ΡΠΈΡ Π½Π΅ ΠΏΡΠ΅Π²ΡΡΠΈΠ»Π° 1 %, Π° ΠΊ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΠΌ Π°Π΄Π°ΠΌΠ°Π½ΡΠ°Π½Π° ΠΎΠΊΠ°Π·Π°Π»ΠΈΡΡ Π½Π΅ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΠΌΠΈ Π²ΡΠ΅ ΠΈΠ·ΡΡΠ΅Π½Π½ΡΠ΅ ΡΠΈΡΠΊΡΠ»ΠΈΡΡΡΡΠΈΠ΅ ΡΡΠ°ΠΌΠΌΡ
ΠΡΠΈΠΏΠΏ-2016: ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΠΈ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ (ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΠΠ£Π Π³ΠΎΡΠΎΠ΄Π° ΠΠΎΡΠΊΠ²Ρ Β«ΠΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½Π°Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ Π±ΠΎΠ»ΡΠ½ΠΈΡΠ° β 1 ΠΠ΅ΠΏΠ°ΡΡΠ°ΠΌΠ΅Π½ΡΠ° Π·Π΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΡ Π³ΠΎΡΠΎΠ΄Π° ΠΠΎΡΠΊΠ²ΡΒ»)
The aim of this study was to monitor in-hospital influenza virus infection during 2015 β 2016 epidemic flu season. Methods. Influenza virus was searched in patients hospitalized to a clinical infectious diseases hospital with acute respiratory viral infection during 2015 β 2016 influenza seasonal growth period using real-time RT-PCR method. Influenza virus was isolated from nasal swabs and autopsy material using canine kidney cell line. Other laboratory methods used included complete blood count, blood chemistry, blood gas analysis, urinalysis, and chest X-ray examination. Results. We examined 1,491 patients (375 adults, 546 children, 570 pregnant women with early gestational age). The proportion of hospitalized patients with confirmed A / H1N1pdm09 influenza in January β February, 2016, was 91.3%. A / H3N2 influenza virus was diagnosed in 5.7%, influenza B virus was isolated in 1.2% of patients. Totally, influenza virus was detected in 35.2% of samples, of which 30.1% of samples were obtained from adults, 33.7% of samples were obtained from children, and 39.8% of samples were obtained from pregnant women. The prevalent patientβs age was 15 to 60 years (76.1%) in adults and 3 to 6 years in children. Moderate course of influenza with a high rate of hospital admission was seen more often and was similar to that of 2009 β 2010 epidemic season. Proportion of patients with flu complicated by pneumonia was higher than that in 2014 β 2015 epidemic season. Bilateral lung injury was diagnosed in 48.4% of patients. High mortality in ICU (46.4%) was due to delayed start of antiviral treatment and late admission to a hospital. Conclusion. In 2015 β 2016 epidemic flu season, higher morbidity, complications and poor outcomes were related to predominant infection of A β H1N1pdm09 influenza virus. Risk factors of complications and death were delayed care seeking, lack of modern antiviral medications and comorbidity.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. Π ΠΏΠ΅ΡΠΈΠΎΠ΄ ΠΏΠΎΠ΄ΡΠ΅ΠΌΠ° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ Π² ΡΠ΅Π·ΠΎΠ½Π΅ 2015β2016 Π³Π³. Π² ΡΠ°ΠΌΠΊΠ°Ρ
ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π½Π°Π΄Π·ΠΎΡΠ° Π·Π° ΡΠΈΡΠΊΡΠ»ΡΡΠΈΠ΅ΠΉ Π²ΠΈΡΡΡΠΎΠ² Π³ΡΠΈΠΏΠΏΠ° Π² Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ Π¦Π΅Π½ΡΡΠΎΠΌ ΡΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ Π³ΡΠΈΠΏΠΏΠ° (Π¦ΠΠΠ) ΠΠ½ΡΡΠΈΡΡΡΠ° Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈΠΌ. Π.Π.ΠΠ²Π°Π½ΠΎΠ²ΡΠΊΠΎΠ³ΠΎ Π€ΠΠΠ£ Β«Π€Π΅Π΄Π΅ΡΠ°Π»ΡΠ½ΡΠΉ Π½Π°ΡΡΠ½ΠΎ-ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΡΠΊΠΈΠΉ ΡΠ΅Π½ΡΡ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ ΠΌΠΈΠΊΡΠΎΠ±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈΠΌΠ΅Π½ΠΈ ΠΏΠΎΡΠ΅ΡΠ½ΠΎΠ³ΠΎ Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠ° Π.Π€.ΠΠ°ΠΌΠ°Π»Π΅ΠΈΒ» ΠΠΈΠ½Π·Π΄ΡΠ°Π²Π° Π ΠΎΡΡΠΈΠΈ (ΠΠΎΡΠΊΠ²Π°) Π½Π° Π±Π°Π·Π΅ ΠΠΠ£Π Π³ΠΎΡΠΎΠ΄Π° ΠΠΎΡΠΊΠ²Ρ Β«ΠΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½Π°Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ Π±ΠΎΠ»ΡΠ½ΠΈΡΠ° β 1 ΠΠ΅ΠΏΠ°ΡΡΠ°ΠΌΠ΅Π½ΡΠ° Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ Π³ΠΎΡΠΎΠ΄Π° ΠΠΎΡΠΊΠ²ΡΒ» (ΠΠΠ£Π Π³. ΠΠΎΡΠΊΠ²Ρ Β«ΠΠΠ β 1 ΠΠΠΒ») ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ»ΡΡ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΡΠΉ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ°, ΡΠ΅Π»ΡΡ ΠΊΠΎΡΠΎΡΠΎΠ³ΠΎ ΡΠ²Π»ΡΠ»ΠΎΡΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΠΈ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΡΠ°ΠΌΠΌΠΎΠ² Π²ΠΈΡΡΡΠΎΠ² Π³ΡΠΈΠΏΠΏΠ° Π ΠΈ Π ΡΡΠ΅Π΄ΠΈ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², Π² Ρ. Ρ. Ρ ΡΡΠΆΠ΅Π»ΠΎΠΉ ΡΠΎΡΠΌΠΎΠΉ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, Π° ΡΠ°ΠΊΠΆΠ΅ Π°Π½Π°Π»ΠΈΠ· ΡΠ°ΡΡΠΎΡΡ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΏΠ΅ΡΠΈΠΎΠ΄ ΠΏΠΎΠ΄ΡΠ΅ΠΌΠ° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ Π³ΡΠΈΠΏΠΏΠΎΠΌ Π² ΠΠΠ£Π Π³. ΠΠΎΡΠΊΠ²Ρ Β«ΠΠΠ β 1 ΠΠΠΒ» Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠΌ ΠΎΡΡΡΠ°Ρ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½Π°Ρ Π²ΠΈΡΡΡΠ½Π°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ. ΠΠ΅ΡΠ΅ΠΊΡΠΈΡ Π²ΠΈΡΡΡΠΎΠ² Π³ΡΠΈΠΏΠΏΠ° ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ°Π·Π½ΠΎΠΉΒ ΡΠ΅ΠΏΠ½ΠΎΠΉΒ ΡΠ΅Π°ΠΊΡΠΈΠΈΒ Ρ ΠΎΠ±ΡΠ°ΡΠ½ΠΎΠΉ ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΈΠ΅ΠΉ Π² ΡΠ΅ΠΆΠΈΠΌΠ΅ ΡΠ΅Π°Π»ΡΠ½ΠΎΠ³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ. ΠΠΈΡΡΡΡ Π³ΡΠΈΠΏΠΏΠ° Π±ΡΠ»ΠΈ ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Ρ ΠΈΠ· Π½Π°Π·Π°Π»ΡΠ½ΡΡ
ΡΠΌΡΠ²ΠΎΠ² ΠΈ ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π° Π½Π° ΠΏΠ΅ΡΠ΅Π²ΠΈΠ²Π°Π΅ΠΌΠΎΠΉ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ Π»ΠΈΠ½ΠΈΠΈ ΠΏΠΎΡΠΊΠΈ ΡΠΎΠ±Π°ΠΊΠΈ (MDCK). ΠΠ°Π±ΠΎΡΠ°ΡΠΎΡΠ½Π°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° Π²ΠΊΠ»ΡΡΠ°Π»Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΈ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΊΡΠΎΠ²ΠΈ, Π°Π½Π°Π»ΠΈΠ· Π³Π°Π·ΠΎΠ²ΠΎΠ³ΠΎ ΡΠΎΡΡΠ°Π²Π° ΠΊΡΠΎΠ²ΠΈ, Π°Π½Π°Π»ΠΈΠ· ΠΌΠΎΡΠΈ, ΡΠ΅Π½ΡΠ³Π΅Π½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΎΡΠ³Π°Π½ΠΎΠ² Π³ΡΡΠ΄Π½ΠΎΠΉ ΠΊΠ»Π΅ΡΠΊΠΈ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π ΡΠ½Π²Π°ΡΠ΅-ΡΠ΅Π²ΡΠ°Π»Π΅ 2016 Π³. Π΄ΠΎΠ»Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
, Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π² ΠΠΠ£Π Π³. ΠΠΎΡΠΊΠ²Ρ Β«ΠΠΠ β 1 ΠΠΠΒ» Ρ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΠΎ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½Π½ΡΠΌ Π³ΡΠΈΠΏΠΏΠΎΠΌ A / H1N1pdm09, ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 91,3 %, A / H3N2 β 5,7 %, Π β 1,2 %. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ (n = 1Β 491) β Π²Π·ΡΠΎΡΠ»ΡΠ΅ (n = 375), Π΄Π΅ΡΠΈ (n = 546) ΠΈ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ (n = 570) Π½Π° ΡΠ°Π·Π½ΡΡ
ΡΡΠΎΠΊΠ°Ρ
. ΠΠΎΠ»Ρ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΡ
Π½Π° Π³ΡΠΈΠΏΠΏ ΠΏΡΠΎΠ± Π² ΡΠ΅Π»ΠΎΠΌ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 35,2 %. Π‘ΡΠ΅Π΄ΠΈ Π²Π·ΡΠΎΡΠ»ΡΡ
ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΠΌΠΈ Π½Π° Π³ΡΠΈΠΏΠΏ Π±ΡΠ»ΠΈ 30,1 % ΠΏΡΠΎΠ±, ΡΡΠ΅Π΄ΠΈ Π΄Π΅ΡΠ΅ΠΉ β 33,7 %, ΡΡΠ΅Π΄ΠΈ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
β 39,8 %. Π Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΠ΅ ΠΏΡΠ΅ΠΎΠ±Π»Π°Π΄Π°Π»ΠΈ (76,1 %) ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 15 Π΄ΠΎ 50 Π»Π΅Ρ. Π Π΄Π΅ΡΡΠΊΠΎΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½Π½ΡΠΌΠΈ Π² ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡ ΠΎΠΊΠ°Π·Π°Π»ΠΈΡΡ Π΄Π΅ΡΠΈ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ 3β6 Π»Π΅Ρ. ΠΡΠ΅ΠΎΠ±Π»Π°Π΄Π°Π»ΠΈ ΡΡΠ΅Π΄Π½Π΅ΡΡΠΆΠ΅Π»ΡΠ΅ ΡΠΎΡΠΌΡ Π³ΡΠΈΠΏΠΏΠ° Ρ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠ°ΡΡΠΎΡΠΎΠΉ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΉ, ΡΡΠ°Π²Π½ΠΈΠΌΠΎΠΉ Ρ ΡΠ΅Π·ΠΎΠ½ΠΎΠΌ 2009β2010 Π³Π³. ΠΠΎΠ»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π³ΡΠΈΠΏΠΏΠΎΠΌ, ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΡΠΌ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠ΅ΠΉ, ΡΠ²Π΅Π»ΠΈΡΠΈΠ»Π°ΡΡ Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠΈ Ρ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ΅Π·ΠΎΠ½ΠΎΠΌ 2014β2015 Π³Π³. ΠΠ²ΡΡΡΠΎΡΠΎΠ½Π½Π΅Π΅ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ Π»Π΅Π³ΠΊΠΈΡ
Π·Π°ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π½ΠΎ Ρ 48,4 % Π±ΠΎΠ»ΡΠ½ΡΡ
. ΠΡΡΠΎΠΊΠΈΠΉ ΡΡΠΎΠ²Π΅Π½Ρ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΡΡΠΈ (46,4 %) Π² ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΈ ΡΠ΅Π°Π½ΠΈΠΌΠ°ΡΠΈΠΈ ΠΈ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΠ²ΡΠ·Π°Π½ Ρ Π·Π°ΠΏΠΎΠ·Π΄Π°Π»ΡΠΌ Π½Π°ΡΠ°Π»ΠΎΠΌ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈ ΠΏΠΎΠ·Π΄Π½Π΅ΠΉ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠ΅ΠΉ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΡΠΎΠΊΠ°Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ, ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΡΠΈΡΠ»Π° ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΡ
ΠΈΡΡ
ΠΎΠ΄ΠΎΠ² ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π° Π΄ΠΎΠΌΠΈΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π²ΠΈΡΡΡΠ° Π³ΡΠΈΠΏΠΏΠ° A / H1N1pdm09. Π€Π°ΠΊΡΠΎΡΠ°ΠΌΠΈ, ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°ΡΡΠΈΠΌΠΈ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈ Π»Π΅ΡΠ°Π»ΡΠ½ΡΡ
ΠΈΡΡ
ΠΎΠ΄ΠΎΠ², ΡΠ²Π»ΡΡΡΡΡ ΠΏΠΎΠ·Π΄Π½Π΅Π΅ ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΠ΅ Π·Π° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΡΡ, ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, ΡΠΎΠΏΡΡΡΡΠ²ΡΡΡΠΈΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ
2012-2013 Seasonal Influenza Vaccine Effectiveness Against Influenza Hospitalizations: Results From The Global Influenza Hospital Surveillance Network
Epidemiology Of Hospital Admissions With Influenza During The 2013/2014 Northern Hemisphere Influenza Season: Results From The Global Influenza Hospital Surveillance Network
Scopu
Influenza Epidemiology And Influenza Vaccine Effectiveness During The 2015-2016 Season: Results From The Global Influenza Hospital Surveillance Network
BackgroundThe Global Influenza Hospital Surveillance Network is an international platform whose primary objective is to study severe cases of influenza requiring hospitalization.MethodsDuring the 2015-2016 influenza season, 11 sites in the Global Influenza Hospital Surveillance Network in nine countries (Russian Federation, Czech Republic, Turkey, France, China, Spain, Mexico, India, and Brazil) participated in a prospective, active-surveillance, hospital-based epidemiological study. Influenza infection was confirmed by reverse transcription-polymerase chain reaction. Influenza vaccine effectiveness (IVE) against laboratory-confirmed influenza was estimated using a test-negative approach.Results9882 patients with laboratory results were included of which 2415 (24.4%) were positive for influenza, including 1415 (14.3%) for A(H1N1)pdm09, 235 (2.4%) for A(H3N2), 180 (1.8%) for A not subtyped, 45 (0.5%) for B/Yamagata-lineage, 532 (5.4%) for B/Victoria-lineage, and 33 (0.3%) for B not subtyped. Of included admissions, 39% were<5years of age and 67% had no underlying conditions. The odds of being admitted with influenza were higher among pregnant than non-pregnant women (odds ratio, 2.82 [95% confidence interval (CI), 1.90 to 4.19]). Adjusted IVE against influenza-related hospitalization was 16.3% (95% CI, 0.4 to 29.7). Among patients targeted for influenza vaccination, adjusted IVE against hospital admission with influenza was 16.2% (95% CI, -3.6 to 32.2) overall, 23.0% (95% CI, -3.3 to 42.6) against A(H1N1)pdm09, and-25.6% (95% CI, -86.3 to 15.4) against B/Victoria lineage.ConclusionsThe 2015-2016 influenza season was dominated by A(H1N1)pdm09 and B/Victoria-lineage. Hospitalization with influenza often occurred in healthy and young individuals, and pregnant women were at increased risk of influenza-related hospitalization. Influenza vaccines provided low to moderate protection against hospitalization with influenza and no protection against the predominant circulating B lineage, highlighting the need for more effective and broader influenza vaccines.Wo
Epidemiology of influenza in pregnant women hospitalized with respiratory illness in Moscow, 2012/2013β2015/2016: a hospital-based active surveillance study
Influenza Epidemiology And Influenza Vaccine Effectiveness During The 2016-2017 Season In The Global Influenza Hospital Surveillance Network (Gihsn)
BackgroundThe Global Influenza Hospital Surveillance Network (GIHSN) aims to determine the burden of severe influenza disease and Influenza Vaccine Effectiveness (IVE). This is a prospective, active surveillance and hospital-based epidemiological study to collect epidemiological data in the GIHSN. In the 2016-2017 influenza season, 15 sites in 14 countries participated in the GIHSN, although the analyses could not be performed in 2 sites. A common core protocol was used in order to make results comparable. Here we present the results of the GIHSN 2016-2017 influenza season.MethodsA RT-PCR test was performed to all patients that accomplished the requirements detailed on a common core protocol. Patients admitted were included in the study after signing the informed consent, if they were residents, not institutionalised, not discharged in the previous 30days from other hospitalisation with symptoms onset within the 7days prior to admission. Patients 5years old or more must also complied the Influenza-Like Illness definition. A test negative-design was implemented to perform IVE analysis. IVE was estimated using a logistic regression model, with the formula IVE=(1-aOR)x100, where aOR is the adjusted Odds Ratio comparing cases and controls.ResultsAmong 21,967 screened patients, 10,140 (46.16%) were included, as they accomplished the inclusion criteria, and tested, and therefore 11,827 (53.84%) patients were excluded. Around 60% of all patients included with laboratory results were recruited at 3 sites. The predominant strain was A(H3N2), detected in 63.6% of the cases (1840 patients), followed by B/Victoria, in 21.3% of the cases (618 patients). There were 2895 influenza positive patients (28.6% of the included patients). A(H1N1)pdm09 strain was mainly found in Mexico. IVE could only be performed in 6 sites separately. Overall IVE was 27.24 (95% CI 15.62-37.27. Vaccination seemed to confer better protection against influenza B and in people 2-4years, or 85years old or older. The aOR for hospitalized and testing positive for influenza was 3.02 (95% CI 1.59-5.76) comparing pregnant with non-pregnant women.ConclusionsVaccination prevented around 1 in 4 hospitalisations with influenza. Sparse numbers didn't allow estimating IVE in all sites separately. Pregnancy was found a risk factor for influenza, having 3 times more risk of being admitted with influenza for pregnant women.Wo